Oxaliplatin Combined with 5-Fluorouracil and Methotrexate in Advanced Colorectal Cancer

Background: A promising regimen including 5-Fluorouracil, methotrexate and oxaliplatin is reported. Patients and Methods: Patients with untreated measurable metastatic disease received bolus 5-Fluorouracil (600 mg/m 2 ) on days 2 and 16, modulated by methotrexate (200 mg/m 2 ) 24 h earlier, alternat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2006-05, Vol.26 (3B), p.2425-2428
Hauptverfasser:	ZAMPINO, M. G, LORIZZO, K, ROCCA, A, LOCATELLI, M, ZORZINO, L, MANZONI, S, MAZZETTA, C, FAZIO, N, BIFFI, R, DE BRAUD, F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Colorectal Neoplasms - blood Colorectal Neoplasms - drug therapy Drug Administration Schedule Female Fluorouracil - administration & dosage Fluorouracil - adverse effects Gastroenterology. Liver. Pancreas. Abdomen Humans Infusions, Intravenous Male Medical sciences Methotrexate - administration & dosage Methotrexate - adverse effects Middle Aged Organoplatinum Compounds - administration & dosage Organoplatinum Compounds - adverse effects Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumors Vascular Endothelial Growth Factor A - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!